Muhammad Arshad Alvi

Muhammad Arshad Alvi

Auto-generated profile, based on publicly available information

Muhammad Arshad Alvi

Department of Pediatric Gastroenterology, Hepatology & Nutrition, The Children’s Hospital & University of Child Health Sciences, Lahore, Pakistan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2023 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
HCHuma Arshad Cheema
Huma Arshad Cheema
ZFZafar Fayyaz
Zafar Fayyaz
ASAnjum Saeed
Anjum Saeed
MAMuhammad Nadeem Anjum
Muhammad Nadeem Anjum
SISadaqat Ijaz
Sadaqat Ijaz
SBSyeda Sara Batool
Syeda Sara Batool
Background/Aims: The purpose of this study was to identify the spectrum and frequency of pathogenic variants as well as the clinical and genetic insight of hereditary chronic pancreatitis in Pakistani children. Materials and Methods: The deoxyribonucleic acid of affected probands of 44 unrelated Pakistani families, having hereditary chronic pancreatitis-affected children, were subjected to massive parallel sequencing for candidate reported genes (SPINK1, PRSS1, CFTR, CPA1, CTRC, CBS, AGL, PHKB, and LPL). Data were analyzed using different bioinformatics tools for the variants and in-silico analysis. All the identified variants were validated by direct sequencing of the targeted exons in the probands and their parents. Results: There were 50 patients included in this study with confirmed hereditary chronic pancreatitis. Nine known mutations in SPINK1, PRSS1, CFTR, CTRC, CBS, and AGL genes, and 10 novel variants in LPL, CFTR, CTR, and PHKB genes were identified. The identified variants were found in heterozygous, compound heterozygous, and trans-heterozygous forms, with rare allele frequency in the normal population. The novel variants were [c.378C>T(p.Lys126Asn) and c.719G>A(p.Arg240Gln) in CTRC, c.586-3C>A and c.763A>G(p.Arg255Gly) in CPA1, c.1160_1161insT(p.Lys387Asnfs*26), c.784C>T(p.Gln262*), c.1139+1G>A, c.175G>A(p.Gly59Arg) in LPL, c.388C>G(p.leu130val) in CFTR, and c.2327G>A(p.Arg776His in PHKB)]. The phenotypic characteristics were variable and correlated with the relevant variant. Conclusions: The genetic composition plays a significant role in the predisposition of hereditary chronic pancreatitis. The clinical presentation varies with the genetic determinant involved. This information would help in building up a diagnostic algorithm for our population that can be used for genetic screening services in affected cohorts.

31 October 2025 in Intestinal Research
Verified
Journal Article
Open access
ITIchiro Takeuchi
Ichiro Takeuchi
KAKatsuhiro Arai
Katsuhiro Arai
PTPornthep Tanpowpong
Pornthep Tanpowpong
MLMing-Wei Lai
Ming-Wei Lai
Andrew DayAndrew Day
Andrew Day
UPUjjal Poddar
Ujjal Poddar
Children diagnosed with inflammatory bowel disease (IBD) before the age of 6 years are considered to have “very early-onset IBD (VEO-IBD),” which is challenging to diagnose and treat. Notably, many children with VEO-IBD have monogenic forms of the disease, meaning that early genetic testing is useful. However, because the prevalence of genetic variants causing VEO-IBD differs globally, the diagnosis and treatment of this disease should be tailored to each region. In the present review paper, the IBD Subcommittee of the Scientific Committee of the Asia-Pacific Society of Pediatric Gastroenterology, Hepatology and Nutrition (APSPGHAN) has summarized the epidemiology, presenting features, diagnosis, and treatment of VEO-IBD in the Asia– Pacific region, with an aim to guide clinicians and researchers who work with VEO-IBD in this area. Our 3 main messages are as follows: endoscopy is essential for VEO-IBD diagnosis; all children diagnosed with VEO-IBD should be suspected of having a monogenic form; and children with suspected monogenic IBD should undergo early genetic testing. Our messages aim to improve the early diagnosis and treatment of VEO-IBD in the Asia–Pacific region, including the early detection of monogenic IBD in this area.

1 January 2026 in Diagnostic and Interventional Endoscopy
Verified
Journal Article
Closed access
HRHooria Rehman
Hooria Rehman
SBSyeda Sara Batool
Syeda Sara Batool
MAMuhammad Nadeem Anjum
Muhammad Nadeem Anjum
MAMuhammad Arshad Alvi
Muhammad Arshad Alvi
ZFZafar Fayyaz
Zafar Fayyaz
HCHuma Arshad Cheema
Huma Arshad Cheema
Objective: Foreign body ingestion is a common presentation in pediatric emergency department. This study highlights the clinical presentation of various foreign bodies, their complications, diagnosis and management with its outcome. Materials and Methods: A cross-sectional data analysis of patients with foreign body ingestion presented between July 2015 to June 2023 at the department of Pediatric Gastroenterology, Hepatology & Nutrition, The Children’s Hospital & University of Child Health Sciences, Lahore Pakistan was conducted. Patients up to 16 years of age with foreign body ingestion were included and coded as Red, Yellow and Green in terms of management. Descriptive statistics, parametric or non-parametric tests, and linear regression analysis were performed. Results: In total, 881 patients were enrolled; the mean age was 4.6±1.8 years (Range 0.11 to 16 years), the male to female ratio was 1.4:1. On an average, 110 cases per year were managed and maximum number of patients was admitted in 2019. Button/ coin battery (329, 37.3%) was the most common ingested foreign body followed by coin ingestion. Complications were most frequently observed with button battery/ coin battery followed by magnets. A total of 475 patients (53.9%) were admitted under the Red code, 233 patients (26.4%) under the Yellow code, and 173 patients (19.6%) under the Green code. Flexible endoscopy was done in 789 (89.5%) and rigid endoscopy was done in 8 (1%) patients and successful retrieval was done in 755 (84.7%) patients. Conclusion: High rate of foreign body ingestion especially button battery/ coin battery ingestion and associated complications were observed. Following the guidelines for diagnosis and management, serious complications can be avoided. Moreover, public awareness and protective measures at government level are needed to stop this trend.

1 August 2024
Verified
Journal Article
Open access
PDF file
HCHuma Arshad Cheema
Huma Arshad Cheema
Aliaksandr SkrahinAliaksandr Skrahin
Aliaksandr Skrahin
ASAnjum Saeed
Anjum Saeed
ZFZafar Fayyaz
Zafar Fayyaz
MAMuhammad Arshad Alvi
Muhammad Arshad Alvi
ARArndt Rolfs
Arndt Rolfs
Progressive familial intrahepatic cholestasis (PFIC) is a rare group of genetic disorders that typically present in infants and children, often progressing to end-stage liver disease. Using whole genome sequencing (WGS) for diagnosis, we aimed to assess phenotypic features and outcomes, in Pakistani children with different types of PFIC. The study included 116 pediatric participants with five PFIC types: PFIC1, ATP8B1 gene (n=19); PFIC2, ABCB11 (n=28); PFIC3, ABCB4 (n=52); PFIC4 TJP2 (n=15); and PFIC5 NR1H4 (n=2). Seventy unique variants were identified across the five genes. Age at genetic diagnosis was higher in PFIC3 patients. Clinical and laboratory findings showed significant overlap among all PFIC types. PFIC3 had a less aggressive course and better survival outcomes than PFIC1, PFIC2, and PFIC4. The cumulative survival rate was significantly higher at 89% (95% CI 43-98%) for patients who underwent liver transplantation, compared to 9% (95% CI 1-29%) for those who did not (p=0.016). The study provides the first comprehensive analysis of PFIC in Pakistani children, highlighting significant clinical overlap and the critical need for early genetic diagnosis using WGS. The findings underscore the importance of personalized treatment approaches, including early consideration for liver transplantation, to improve patient outcomes.